ADDL.F Stock Overview

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details

ADDL.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	1/6
Financial Health	2/6
Dividends	3/6

Rewards

Trading at 40.8% below our estimate of its fair value

Earnings are forecast to grow 15.17% per year

Risk Analysis

Shares are highly illiquid

Debt is not well covered by operating cash flow

Large one-off items impacting financial results

Profit margins (4.2%) are lower than last year (7.1%)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

AddLife AB (publ) Competitors

Sotera Health

NasdaqGS:SHC

US$3.8b

Stevanato Group

NYSE:STVN

US$6.1b

Medpace Holdings

NasdaqGS:MEDP

US$10.8b

Bruker

NasdaqGS:BRKR

US$9.1b

Price History & Performance

Summary of share price highs, lows and changes for AddLife
Historical stock prices
Current Share Price	SEK 7.94
52 Week High	SEK 7.94
52 Week Low	SEK 7.94
Beta	1.12
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-68.24%

Recent updates

Shareholder Returns

	ADDL.F	US Life Sciences	US Market
7D	0%	4.1%	2.4%
1Y	n/a	3.4%	25.0%

Return vs Industry: Insufficient data to determine how ADDL.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how ADDL.F performed against the US Market.

Price Volatility

Is ADDL.F's price volatile compared to industry and market?
ADDL.F volatility
ADDL.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	10.1%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.3%

Stable Share Price: ADDL.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ADDL.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1906	2,296	Fredrik Dalborg	www.add.life

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments.

AddLife AB (publ) Fundamentals Summary

How do AddLife's earnings and revenue compare to its market cap?
ADDL.F fundamental statistics
Market cap	US$666.72m
Earnings (TTM)	US$35.11m
Revenue (TTM)	US$839.12m

19.0x

P/E Ratio

0.8x

P/S Ratio

Is ADDL.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADDL.F income statement (TTM)
Revenue	SEK 9.25b
Cost of Revenue	SEK 5.81b
Gross Profit	SEK 3.44b
Other Expenses	SEK 3.05b
Earnings	SEK 387.00m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Oct 26, 2023

Earnings per share (EPS)	3.18
Gross Margin	37.15%
Net Profit Margin	4.18%
Debt/Equity Ratio	104.5%

How did ADDL.F perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

38%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/15 18:50
End of Day Share Price	2023/07/19 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AddLife AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Karl Norén	Danske Bank
Gustav Berneblad	Nordea Markets